Welcome to LookChem.com Sign In|Join Free

CAS

  • or

723260-69-3

2,5-dibromo-N-isopentylbenzamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

723260-69-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 723260-69-3 Structure

  • Basic information

    1. Product Name: 2,5-dibromo-N-isopentylbenzamide
    2. Synonyms: 2,5-dibromo-N-isopentylbenzamide
    3. CAS NO:723260-69-3
    4. Molecular Formula: C12H15Br2NO
    5. Molecular Weight: 349.0616
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 723260-69-3.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 2,5-dibromo-N-isopentylbenzamide(CAS DataBase Reference)
    10. NIST Chemistry Reference: 2,5-dibromo-N-isopentylbenzamide(723260-69-3)
    11. EPA Substance Registry System: 2,5-dibromo-N-isopentylbenzamide(723260-69-3)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 723260-69-3(Hazardous Substances Data)

723260-69-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 723260-69-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,2,3,2,6 and 0 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 723260-69:
(8*7)+(7*2)+(6*3)+(5*2)+(4*6)+(3*0)+(2*6)+(1*9)=143
143 % 10 = 3
So 723260-69-3 is a valid CAS Registry Number.

723260-69-3Downstream Products

723260-69-3Relevant articles and documents

Structure-Activity Studies Reveal Scope for Optimisation of Ebselen-Type Inhibition of SARS-CoV-2 Main Protease

Thun-Hohenstein, Siegfried T. D.,Suits, Timothy F.,Malla, Tika R.,Tumber, Anthony,Brewitz, Lennart,Choudhry, Hani,Salah, Eidarus,Schofield, Christopher J.

supporting information, (2021/12/30)

The reactive organoselenium compound ebselen is being investigated for treatment of coronavirus disease 2019 (COVID-19) and other diseases. We report structure-activity studies on sulfur analogues of ebselen with the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) main protease (Mpro), employing turnover and protein-observed mass spectrometry-based assays. The results reveal scope for optimisation of ebselen/ebselen derivative- mediated inhibition of Mpro, particularly with respect to improved selectivity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 723260-69-3